Earnings Call · Q4 FY2024·2025-03-10

Q4 24EPS -100.00%*·Rev n/aQ3 24EPS +90.91%·Rev n/aQ2 24EPS +46.15%·Rev n/aQ1 24EPS -52.38%·Rev n/a⚠ consensus missing

Coherus Oncology, Inc. CHRS

Jodi Sievers — Investor Relations or similar communications role

Denny Lanfear — Chief Executive Officer

Paul Reider — Chief Commercial Officer

Sameer Goregaoker — Chief Commercial Officer or Head of Commercial Operations

Theresa LaVallee — Chief Medical Officer or Senior Medical Executive

Rosh Dias — Head of Clinical Development or similar senior clinical role

Bryan McMichael — Chief Financial Officer

+1.0%1d on move date+1.8% vs SPY3d−14.4%5d−12.0%

Research tier

Behavioral profile computed for 7 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CHRS calls or request research access.

More CHRS calls Browse calls Request research access